Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3250 of 3284 entries
View as:

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Phase: N/A Priority: Normal
NCT ID: NCT00944918 Org: User:
Start: 12/31/08 End: 06/30/11 Due: 06/30/12

To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately

Phase: N/A Priority: Normal
NCT ID: NCT01535677 Org: User:
Start: 04/30/13 End: 07/31/13 Due: 07/31/14

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Phase: N/A Priority: Normal
NCT ID: NCT00497679 Org: User:
Start: 08/31/06 End: 07/31/07 Due: 07/31/08

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01839604 Org: User:
Start: 05/31/13 End: 02/28/15 Due: 02/28/16

DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia

Phase: N/A Priority: Normal
NCT ID: NCT00241488 Org: User:
Start: 06/30/03 End: 02/28/07 Due: 02/28/08

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

Phase: N/A Priority: Normal
NCT ID: NCT01210339 Org: User:
Start: 11/30/10 End: 08/31/11 Due: 08/31/12

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017

Phase: N/A Priority: Normal
NCT ID: NCT00791752 Org: User:
Start: 11/30/08 End: 03/31/09 Due: 03/31/10

30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00680017 Org: User:
Start: 06/30/08 End: 04/30/11 Due: 04/30/12

Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01397890 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Phase: N/A Priority: Normal
NCT ID: NCT00235937 Org: User:
Start: 12/31/01 End: 12/31/06 Due: 12/31/07

Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study

Phase: N/A Priority: Normal
NCT ID: NCT00670371 Org: User:
Start: 03/31/08 End: 11/30/09 Due: 11/30/10

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01606007 Org: User:
Start: 07/31/12 End: 01/31/14 Due: 01/31/15

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03725475 Org: User:
Start: 11/26/18 End: 09/30/19 Due: 09/30/20

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00977626 Org: User:
Start: 10/31/09 End: 05/31/10 Due: 05/31/11

Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05573724 Org: User:
Start: 11/07/22 End: 05/17/24 Due: 05/17/25

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

Phase: N/A Priority: Normal
NCT ID: NCT02542293 Org: User:
Start: 11/03/15 End: 12/31/25 Due: 12/31/26

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02453282 Org: User:
Start: 07/21/15 End: 12/31/25 Due: 12/31/26

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05498155 Org: User:
Start: 11/07/22 End: 12/31/26 Due: 12/31/27

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02063204 Org: User:
Start: 03/31/14 End: 07/31/14 Due: 07/31/15

MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA

Phase: N/A Priority: Normal
NCT ID: NCT06422676 Org: User:
Start: 12/29/23 End: 12/18/24 Due: 12/18/25

Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02878252 Org: User:
Start: 10/04/16 End: 04/28/17 Due: 04/28/18

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00997945 Org: User:
Start: 10/31/09 End: 04/30/11 Due: 04/30/12

Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)

Phase: N/A Priority: Normal
NCT ID: NCT00278889 Org: User:
Start: 01/31/06 End: 10/31/09 Due: 10/31/10

AZD1152 in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00338182 Org: User:
Start: 05/23/06 End: 03/01/17 Due: 03/01/18

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT06465810 Org: User:
Start: 06/25/24 End: 12/29/31 Due: 12/29/32